EV
The startup develops a balloon-based drug delivery platform specifically designed for the treatment of peripheral vascular disease and uncontrolled hypertension. This technology enables healthcare professionals to effectively manage re-stenosis by delivering therapeutic agents directly to affected vascular sites.
Updated 3 months ago
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a balloon-based drug delivery platform specifically designed for the treatment of peripheral vascular disease and uncontrolled hypertension. This technology enables healthcare professionals to effectively manage re-stenosis by delivering therapeutic agents directly to affected vascular sites.